Michael Myers, Chief Executive Officer at Quoin Pharmaceuticals, Ltd. (QNRX), bought 37,894 shares at $0.66 ($29K) on 2024-09-04, disclosed to the SEC on 2024-09-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.62 | 800 | $496 | 1.7% |
| 2 | $0.66 | 5,322 | $4K | 12.1% |
| 3 | $0.75 | 8,200 | $6K | 21.2% |
| 4 | $0.80 | 23,572 | $19K | 65.0% |
| Total | $0.77 avg | 37,894 | $29K | 100% |
| Filing → |
| INPH | BUY | 2012-05-23 | $29K | — | Filing → |
| INPH | SELL | 2012-04-20 | $62K | — | Filing → |
| INPH | SELL | 2012-04-17 | $52K | — | Filing → |